Skip to main content

News

Chronic heart failure: patients show individual therapy response to ACE inhibitor treatment

– , Medicine & Science

Study supports the efforts to develop a targeted therapy in heart failure

Bariatric surgery saves money and prolongs lives

– , University , Medicine & Science

Action day for obesity patients at MedUni Vienna on 26 May 2018

New study provides rationale for use of a multi-target anticancer drug in patients with malignant pleural mesothelioma

– , Medicine & Science

The small molecule anticancer drug nintedanib shows promising effectiveness in stopping the growth of human malignant pleural mesothelioma

Eva Dichand voted in as new Chair of MedUni Vienna's University Council

– , University , Organisation

Irene Virgolini completes the Council as its fifth member

Thomas Reiberger and Michael Trauner win Gilead Sciences International Liver Research Scholarship

– , People of the MedUni Vienna

Experts from the Division of Gastroenterology and Hepatology win generous research award for study into liver cirrhosis

HIV infection: heart muscle cells die even during the acute phase

– , Medicine & Science

During the first few days of an HIV infection most patients experience flu-like symptoms, which soon disappear without any treatment

Richard Crevenna awarded "Portele" by professional association of DMTF+MAB Austria

– , People of the MedUni Vienna

Head of the Department of Physical Medicine, Rehabilitation and Occupational Medicine honoured for services to interdisciplinary cooperation

Programme for Vienna Children's University (KinderuniVienna) 2018 is out

– , University , Organisation

The theme at MedUni Vienna is: "Health detectives – On the trail of rare diseases"

Hereditary bowel cancer: mesalazine attenuates tumour formation by 50%

– , Medicine & Science

Lynch syndrome patients develop tumours less frequently and the number of tumours that develop is significantly reduced.